Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-12-02
2000-07-18
Ambrose, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514326, 544295, 544360, 544364, 544372, 546208, A61K 31496, C07D40106, C07D40306
Patent
active
060908092
ABSTRACT:
Novel piperzine derivatives substituted on one nitrogen by an aromatic system and on the other nitrogen by (2,5-dioxopyrrolidin)-1-yl) alkanes or (2,6-dioxopiperidin-1-yl) alkanes have been found to exhibit selective .alpha..sub.1A adrenergic activity. The compounds are useful for treatment of disease conditions, such as peripheral vascular disease, congestive heart failure, hypertension and especially benign prostatic hypertrophy.
REFERENCES:
patent: 4479954 (1984-10-01), Hirose et al.
patent: 4675403 (1987-06-01), Abou-Gharbia et al.
Chilmonczyk, Zdzislaw, et al., "Conformational Flexibity of Serotonin1A Receptor Ligands from Crystallographic Data. Updated Model of the Receptor Pharmacophore", Chemical Abstracts 127:234308, vol. 127, No. 17 (1997).
Dimoglo, A.S. et al., "Study of Structure-Activity Relations in a Series of Buspirone Analogs Using an Electron-Topological Approach", Chemical Abstracts 129: 22916, vol. 129, No. 3 (1998).
Hays, Sheryl J., "Synthesis of Carbon-14 Labeled CI-926 and CI-927, New Antihypertensives," Chemical Abstracts 108:21844 vol. 108, No. 3 (1988).
Ishizumi, Kikuo et al., "Synthesis and Anxiolytic Activity of N-substituted Cyclic Imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-Pyrimidinyl)-1-Piperazinyl]Butyl]-2,3-Bicyclo [2.2.1]Heptanedicarboximide (Tandospirone) and Related Compounds", Chem. Pharm., Bull., vol. 39, No. 9 (1991) pp. 2288-2300.
Khadilkar, B.M. et al., "Synthesis and Pharmacology of Some 2-[3-(4-Aryl-1-Piperaxinyl)-Propyl]-1H-Benz[De]Isoquinolin-1,3(2H)-Diones" , Chemical Abstracts 107:198046, vol. 107, No. 21 (1987).
Khadilkar, B.M., et al., "Synthesis and Hypotensive Activity of Some Succinimide Derivatives", Chemical Abstracts 119:27951, vol. 119, No. 3 (1993).
Ryan, M.J., et al., "CI-926 (3-[4-[4-(3-Methylphenyl)-1-Piperazinyl]Butyl]2,4-Imidazolinedione):Antihy pertensive Profile and Pharmacology", Chemical Abstracts 105:164679, vol. 105, No. 19 (1986).
Wu, Yao-Hua, et al., "Psychosedative Agents. N-(4-Phenyl-1-Piperazinylalkyl)-Substituted Cyclic Imides", J. Med. Chem., vol. 12 (1969) pp. 876-881.
Wu, Y. et al. Journal of Medicinal Chemistry 1969, 12, 876-881.
Anand Nitya
Jain Sanjay
Mehta Anita
Saxena Anil Kumar
Sinha Neelima
Ambrose Michael G.
Deshmukh, Esq. Jayadeep R.
Ranbaxy Laboratories Limited
LandOfFree
1-(4-arylpiperazin-1-yl)-.omega.-[n-(.alpha... omega.-dicarboxim does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(4-arylpiperazin-1-yl)-.omega.-[n-(.alpha... omega.-dicarboxim, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(4-arylpiperazin-1-yl)-.omega.-[n-(.alpha... omega.-dicarboxim will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037350